Dr. Elliott Bennett-Guerrero has been a professor of anesthesiology at Stony Brook University since 2015, where he also serves as vice chair of clinical research and innovation in the anesthesiology department. Currently, Dr. Elliott Bennett-Guerrero is participating in a research study conducted by Stony Brook Medicine aimed at determining the efficacy of treatments for COVID-19 using the plasma of recovered patients.
As the novel coronavirus continues to rock the globe, health care professionals and researchers are working constantly towards new treatments and potential vaccines to stop the spread of the virus. One such avenue of research uses plasma from recovered COVID-19 patients. Though not thought of as a cure, convalescent plasma has shown great promise as a way to help COVID-19 patients recover faster. The concept of convalescent plasma as a treatment has been around for more than a century, and it has been used in the past to treat other respiratory afflictions, including during the 1918 influenza epidemic. Convalescent plasma is the liquid component of human blood left over when stripped of red and white blood cells. The theory behind this type of treatment is that the plasma of humans that have recovered from an illness will be rich with antibodies that can help the body fight the illness. Patients with COVID-19 receive convalescent plasma from survivors of the same disease in the hopes that the antibodies will help them recover faster. Early administration of this treatment is particularly important, as researchers believe the extra antibodies can help patients recover faster when they have not yet developed enough antibodies on their own.
0 Comments
|
AuthorDr. Elliott Bennett-Guerrero is both an educator and a vice chairman at Stony Brook Medicine. Archives
June 2022
Categories
All
|